收藏切换
Advances in clinical application of immunotherapy for triple-negative breast cancer
收藏切换
Liang ZHANG1, 2, Yanqiang YANG1, 3, Zifang WU4, *, Jiuyang LIU1, *
World Clinical Drug | 2024, 45(8) : 803 - 808
Less
收藏切换
World Clinical Drug | 2024, 45(8): 803-808
• Topic •
Advances in clinical application of immunotherapy for triple-negative breast cancer
Full
Liang ZHANG1, 2, Yanqiang YANG1, 3, Zifang WU4, *, Jiuyang LIU1, *
Affiliations
  • 1.Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China
  • 2.Department of Oncology, Urumqi Friendship Hospital, Urumqi 830049, Xinjiang Uygur Autonomous Region, China
  • 3.Department of General Surgery, People's Hospital of Gannan Tibetan Autonomous Prefecture of Gansu Province, Gannan 747000, Gansu Province, China
  • 4.Department of Ultrasound Imaging, Wuhan University Hospital, Wuhan 430071, Hubei Province, China
Published: 2024-08-10 doi: 10.13683/j.wph.2024.08.001
Outline
收藏切换

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is negative for estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2, and is significantly more aggressive and progressive than other subtypes. At present, the main treatment is surgery combined chemotherapy, but treatment efficacy of the advanced TNBC patients is poor. With the in-depth study of TNBC immune microenvironment, immunotherapy has shown potential therapeutic value. The immunotherapy of TNBC mainly includes immune checkpoint blockers, cell therapy, tumor vaccines and adjustment of tumor microenvironment. This article reviewed and summarized the current status and progress of immunotherapy, which contributed to the new understanding of TNBC immunotherapy.

triple-negative breast cancer  /  immunotherapy  /  tumor microenvironment
张亮, 杨彦强, 吴梓芳, 刘九洋. 三阴性乳腺癌免疫治疗的临床应用进展. 世界临床药物, 2024 , 45 (8) : 803 -808 . DOI: 10.13683/j.wph.2024.08.001
Liang ZHANG, Yanqiang YANG, Zifang WU, Jiuyang LIU. Advances in clinical application of immunotherapy for triple-negative breast cancer[J]. World Clinical Drug, 2024 , 45 (8) : 803 -808 . DOI: 10.13683/j.wph.2024.08.001
Year 2024 volume 45 Issue 8
17
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.08.001
  • Receive Date:2024-05-29
  • Online Date:2026-11-17
  • Published:2024-08-10
Article Data
Affiliations
History
  • Received:2024-05-29
Affiliations
    1.Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China
    2.Department of Oncology, Urumqi Friendship Hospital, Urumqi 830049, Xinjiang Uygur Autonomous Region, China
    3.Department of General Surgery, People's Hospital of Gannan Tibetan Autonomous Prefecture of Gansu Province, Gannan 747000, Gansu Province, China
    4.Department of Ultrasound Imaging, Wuhan University Hospital, Wuhan 430071, Hubei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.08.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT